At this session we will explore chronic disease trends, focus in on some not so well recognized chronic diseases, and explore chronic disease prevention, treatment and management. Experts will discuss the impact of chronic diseases on patients and on benefit plans. We will also explore options to proactively work with patients to detect these conditions early and manage them for optimal health outcomes.

This will be a great opportunity to explore the impact that plan design, education, wellbeing and disease management initiatives can have on chronic disease management and benefit plan experience.


The Numbers Behind Chronic Disease
Joe Farago, Executive Director, Innovative Medicines Canada

Focus on Chronic Disease
Asthma and COPD – Lara Kassem, Pharm.D., Family Medicine Group Consulting Pharmacists, GMF du Cherin de la Station St-Henri
Cystic Fibrosis – Kim Steele, Director, Government and Community Relations, Cystic Fibrosis Canada

Wellbeing and Chronic Disease Prevention and Management 
Dr. Steven Grover, M.D., Professor of Medicine, McGill University and Director, The McGill Comprehensive Health Improvement Plan (CHIP)

The Link Between Chronic Disease and Disability Management
Liz Scott PhD, CEO and Principal of Organizational Solutions Inc. (OSI)

CE Credits

If you are located anywhere in Canada except Alberta, you will receive
2.5 CE Credits when you participate in this session.


Thank you to our Benefits Breakfast Club (BBC) sponsors for their support during COVID-19:

National sponsors Abbvie, AMGEN, Astra Zeneca, GlaxoSmithKline, Janssen Inc., Lilly, Novartis, Novo Nordisk and Roche

Emerging sponsors The Canadian Association of Optometrists, Gilead, Innovative Medicines Canada, MHCSI & Sobeys Pharmacy

Ontario regional sponsor Abbott.

All have renewed for our 2021-22 season and we are looking forward to working with them again.